These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36669639)

  • 21. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 22. Pleural fluid amino-terminal brain natriuretic peptide in patients with pleural effusions.
    Cincin A; Abul Y; Ozben B; Tanrikulu A; Topaloglu N; Ozgul G; Karakurt S; Oktay A
    Respir Care; 2013 Feb; 58(2):313-9. PubMed ID: 22710710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of B-type natriuretic peptide and NT-proBNP in the diagnosis of pleural effusions due to heart failure.
    Porcel JM
    Curr Opin Pulm Med; 2011 Jul; 17(4):215-9. PubMed ID: 21415751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
    deFilippi CR; Seliger SL; Maynard S; Christenson RH
    Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.
    Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL
    Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
    ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements.
    Hezzell MJ; Rush JE; Humm K; Rozanski EA; Sargent J; Connolly DJ; Boswood A; Oyama MA
    J Vet Intern Med; 2016; 30(2):536-42. PubMed ID: 26813037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.
    Januzzi JL; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Rivers EJ; Walters EL; Gaggin HK;
    J Am Coll Cardiol; 2018 Mar; 71(11):1191-1200. PubMed ID: 29544601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
    Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers of heart failure in pleural fluid.
    Porcel JM; Martínez-Alonso M; Cao G; Bielsa S; Sopena A; Esquerda A
    Chest; 2009 Sep; 136(3):671-677. PubMed ID: 19363209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
    Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
    Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining the optimal cutoff values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years.
    Lin CW; Zeng XL; Zhang JF; Meng XH
    J Card Fail; 2014 Mar; 20(3):168-73. PubMed ID: 24361777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal-pro-B-type natriuretic peptide (NT-proBNP): reference range for Chinese apparently healthy people and clinical performance in Chinese elderly patients with heart failure.
    Shi X; Xu G; Xia T; Song Y; Lin Q
    Clin Chim Acta; 2005 Oct; 360(1-2):122-7. PubMed ID: 16002063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible heart failure.
    Robaei D; Koe L; Bais R; Gould I; Stewart T; Tofler GH
    Ann Clin Biochem; 2011 May; 48(Pt 3):212-7. PubMed ID: 21398433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.
    Wong LL; Zou R; Zhou L; Lim JY; Phua DCY; Liu C; Chong JPC; Ng JYX; Liew OW; Chan SP; Chen YT; Chan MMY; Yeo PSD; Ng TP; Ling LH; Sim D; Leong KTG; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lund M; Devlin G; Troughton R; Cameron VA; Doughty RN; Lam CSP; Too HP; Richards AM
    J Am Coll Cardiol; 2019 Mar; 73(11):1300-1313. PubMed ID: 30898206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score.
    Baggish AL; Siebert U; Lainchbury JG; Cameron R; Anwaruddin S; Chen A; Krauser DG; Tung R; Brown DF; Richards AM; Januzzi JL
    Am Heart J; 2006 Jan; 151(1):48-54. PubMed ID: 16368291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea.
    Murray H; Cload B; Collier CP; Sivilotti ML
    CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
    Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.